10Alvarsson M,Sundkvist G,Lager I,et al.Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabieic patients[J].Diabetes Care,2003,26(8):2231.
2The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Repot of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 1997, 20: 1183- 1197.
3Feata A D, Agostino R Jr, Hanley AJ, et al. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes, 2004,53: 1549-1555.
4Unwin N, Shaw J, Zimmet P, et al. Impaired glucose tolerance and impaired fasting glycemia: the current status on definition and intervention. Diabet Med, 2002,19:708-723.
5Choi KM, Lee J, Kim DR, et al. Comparison of ADA and WHO criteria for the diagnosis of diabetes in elderly Koreans. Diabet Med, 2002,19:853-857.
6The DECODE Study Group: Glucose tolerance and mortality: comparison of WHO and ADA diagnostic criteria. Lancet, 1999,354: 617-621.
7Jia WP, Pang C, Chen L, et al. Epidemiological Characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up in Shanghai urban communities. Diabetologia, 2007,50:286- 292.
8Abdul-Ghani MA, Tfipathy D, Jenckinson C, et al. Insulin secretion and insulin action in subjects with impaired fasting glucose and impaired tolerance : results from the Veterans Administration Genetic Epidemiology Study(VEGAS). Diabetes, 2006,22:345-356.
9Tripathy D, Carlesson M, Almgren P, et al. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes, 2000,49:975-980.
10Meyer C, Pimenta W, Woerle HJ, et al. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care, 2006,22 : 1909-1914.
1Donga E iVan Dijl~ M, Hoogma RPLM,et al. Insulin resistancein multiple tissues tissues in patients with type 1 diabetes mellitus onlong- term continuous subcutaneous insuin infusion therapy [ J ]. Diabetes Metab Res Rev,2013,29( 1 ) :33-38.
2Kentaro Y, Takahisa K, Shigeki O, et al. The Significance of Measuring Body Fat Percentage Determined by BioelectricalImpedance Analysis tor Detecting Subjects With Cardiovascular Disease Risk Factors [J].Circulation Journal, 2012,76 ( 9 ) : 2435- 2442.
3Weng J,Li Y, Xu W, et al. Effect of intensive insulin therapy onbeta- cell function and glycaemic control in patients with newlydiagnosed type 2 diabetes:a muhicentre randomised parallel - group trial[ J]. Lancet,2008,371 (9626) : 1753-1760.
